Type 2 diabetes can be easily managed with a healthy lifestyle, especially related to diet, exercise, and weight management. Despite this, type 2 diabetes is on the rise throughout the world and in the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK), likely due to the fact that obesity and sedentary lifestyles are on the rise.
Features and benefits
- Gain insight to market potential, including a robust 10-year epidemiology forecast of prevalent type 2 diabetes and impaired glucose tolerance cases.
- Understand the key epidemiologic risk factors associated with type 2 diabetes and impaired glucose tolerance.
Type 2 diabetes is the more common form of the disease. The number of diagnosed prevalent cases of type 2 diabetes will increase across all seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK), from approximately 31,243,000 cases to 35,633,000 cases during the forecast period to 2019; the US will see the greatest increase.The number of cases of impaired glucose tolerance (IGT) will increase during the forecast period in the US (27,201,300 to 31,121,000 cases) and in the five major EU markets (France, Germany, Italy, Spain, and the UK) (15,500,100 to 16,527,300 cases), and will slightly decline in Japan due to the forecasted falling population.The rise in the prevalence of both type 2 diabetes and impaired glucose tolerance will be most significant in those aged 60-79 years old, mirroring the rapid growth in this age group in all seven countries.
Your key questions answered
- What are the most robust epidemiologic studies for type 2 diabetes prevalence data?
- How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure and risk factors affect the number of prevalent type 2 diabetes cases in the forecast period?